ScienceAlert on MSN4d
Scientists May Have Discovered a Natural Alternative to Ozempic
Scientists may have identified a way to naturally regulate blood sugar levels and sugar cravings in a similar fashion to ...
Business Insider1mon
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
today announced the acquisition of CX11 (also known as VCT220), an oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA), for worldwide (excluding Greater China) development and ...
JPM 2025: WuXi AppTec rebuffs concern about lower GLP-1 demand after Lilly’s low revenue forecast
Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.
BioWorld1mon
Structure Therapeutics selects lead oral DACRA for obesity
Structure Therapeutics Inc. has selected a lead oral small-molecule amylin receptor agonist ... that is being evaluated for use either alone or in combination with glucagon-like peptide-1 (GLP-1) ...